LOPINAVIR\RITONAVIR: 8,294 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
8,294
Total FAERS Reports
1,118 (13.5%)
Deaths Reported
2,162
Hospitalizations
8,294
As Primary/Secondary Suspect
357
Life-Threatening
89
Disabilities
First Report: 1993 · Latest Report: 20250807
What Are the Most Common LOPINAVIR\RITONAVIR Side Effects?
#1 Most Reported
Off label use
2,010 reports (24.2%)
#2 Most Reported
Foetal exposure during pregnancy
932 reports (11.2%)
#3 Most Reported
Drug interaction
821 reports (9.9%)
All LOPINAVIR\RITONAVIR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 2,010 | 24.2% | 370 | 798 |
| Foetal exposure during pregnancy | 932 | 11.2% | 147 | 101 |
| Drug interaction | 821 | 9.9% | 189 | 233 |
| Depression | 551 | 6.6% | 135 | 98 |
| Virologic failure | 428 | 5.2% | 20 | 33 |
| Exposure during pregnancy | 395 | 4.8% | 36 | 71 |
| Diarrhoea | 363 | 4.4% | 38 | 148 |
| Maternal exposure during pregnancy | 311 | 3.8% | 31 | 71 |
| Product use in unapproved indication | 282 | 3.4% | 76 | 135 |
| Nausea | 243 | 2.9% | 9 | 83 |
| Pathogen resistance | 234 | 2.8% | 16 | 25 |
| Lipodystrophy acquired | 230 | 2.8% | 0 | 16 |
| Acute kidney injury | 226 | 2.7% | 38 | 96 |
| Drug ineffective | 220 | 2.7% | 30 | 81 |
| Drug resistance | 220 | 2.7% | 19 | 44 |
| Neurodevelopmental disorder | 217 | 2.6% | 0 | 0 |
| Vomiting | 209 | 2.5% | 26 | 91 |
| Viral mutation identified | 207 | 2.5% | 3 | 4 |
| Abortion spontaneous | 192 | 2.3% | 34 | 40 |
| Condition aggravated | 190 | 2.3% | 35 | 139 |
Who Reports LOPINAVIR\RITONAVIR Side Effects? Age & Gender Data
Gender: 37.2% female, 62.8% male. Average age: 47.1 years. Most reports from: US. View detailed demographics →
Is LOPINAVIR\RITONAVIR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 6 | 0 | 1 |
| 2001 | 8 | 0 | 0 |
| 2002 | 29 | 1 | 13 |
| 2003 | 19 | 3 | 6 |
| 2004 | 41 | 0 | 14 |
| 2005 | 50 | 8 | 16 |
| 2006 | 36 | 5 | 20 |
| 2007 | 41 | 6 | 18 |
| 2008 | 50 | 1 | 11 |
| 2009 | 81 | 6 | 19 |
| 2010 | 132 | 23 | 68 |
| 2011 | 64 | 7 | 14 |
| 2012 | 116 | 25 | 41 |
| 2013 | 105 | 2 | 25 |
| 2014 | 267 | 22 | 69 |
| 2015 | 185 | 12 | 58 |
| 2016 | 159 | 20 | 62 |
| 2017 | 119 | 15 | 65 |
| 2018 | 104 | 9 | 44 |
| 2019 | 64 | 0 | 15 |
| 2020 | 1,642 | 340 | 515 |
| 2021 | 53 | 3 | 10 |
| 2022 | 69 | 0 | 17 |
| 2023 | 41 | 3 | 10 |
| 2024 | 28 | 0 | 11 |
| 2025 | 19 | 1 | 13 |
What Is LOPINAVIR\RITONAVIR Used For?
| Indication | Reports |
|---|---|
| Hiv infection | 3,387 |
| Covid-19 | 1,549 |
| Product used for unknown indication | 840 |
| Covid-19 pneumonia | 727 |
| Coronavirus infection | 388 |
| Antiretroviral therapy | 376 |
| Maternal exposure timing unspecified | 278 |
| Acquired immunodeficiency syndrome | 125 |
| Antiviral treatment | 89 |
| Prophylaxis against hiv infection | 86 |
LOPINAVIR\RITONAVIR vs Alternatives: Which Is Safer?
LOPINAVIR\RITONAVIR vs LOPRAZOLAM
LOPINAVIR\RITONAVIR vs LORATADINE
LOPINAVIR\RITONAVIR vs LORATADINE\PSEUDOEPHEDRINE
LOPINAVIR\RITONAVIR vs LORAZEPAM
LOPINAVIR\RITONAVIR vs LORCASERIN
LOPINAVIR\RITONAVIR vs LORLATINIB
LOPINAVIR\RITONAVIR vs LORMETAZEPAM
LOPINAVIR\RITONAVIR vs LORNOXICAM
LOPINAVIR\RITONAVIR vs LOSARTAN
LOPINAVIR\RITONAVIR vs LOSARTAN\LOSARTAN
Official FDA Label for LOPINAVIR\RITONAVIR
Official prescribing information from the FDA-approved drug label.